ADMA BIOLOGICS
ADMA is a specialty immune globulin company that develops, manufactures and intends to market plasma-based biologics targeted to niche patient populations for the treatment and prevention of certain infectious diseases. The Company’s target patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disease or who may be immune-suppressed for medical reasons. ADMA also operates ADMA BioCenters, FDA-licensed source plasma collection facilities which provide a portion of blood plasma for the manufacturing of the Company’s lead product candidate RI-002.
ADMA BIOLOGICS
Industry:
Biotechnology Health Care Manufacturing Medical
Founded:
2004-01-01
Address:
Ramsey, New Jersey, United States
Country:
United States
Website Url:
http://www.admabiologics.com
Total Employee:
51+
Status:
Active
Contact:
(201)478-5552
Email Addresses:
[email protected]
Total Funding:
547.35 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager Content Delivery Network Google Universal Analytics Apache
Similar Organizations
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2017-06-06 | Biotest - Therapy business | Biotest - Therapy business acquired by ADMA Biologics | N/A |
Investors List
Hayfin Capital Management
Hayfin Capital Management investment in Post-IPO Debt - ADMA Biologics
Perceptive Advisors
Perceptive Advisors investment in Post-IPO Debt - ADMA Biologics
Marathon Asset Management
Marathon Asset Management investment in Post-IPO Debt - ADMA Biologics
Oxford Finance LLC
Oxford Finance LLC investment in Post-IPO Debt - ADMA Biologics
Oxford Finance LLC
Oxford Finance LLC investment in Post-IPO Debt - ADMA Biologics
Hercules Capital
Hercules Capital investment in Post-IPO Debt - ADMA Biologics
Hercules Capital
Hercules Capital investment in Post-IPO Debt - ADMA Biologics
Hercules Capital
Hercules Capital investment in Debt Financing - ADMA Biologics
Biomark Capital
Biomark Capital investment in Venture Round - ADMA Biologics
Aisling Capital
Aisling Capital investment in Venture Round - ADMA Biologics
Official Site Inspections
http://www.admabiologics.com Semrush global rank: 2.07 M Semrush visits lastest month: 10.08 K
- Host name: 199.60.103.92
- IP address: 199.60.103.92
- Location: Canada
- Latitude: 43.6319
- Longitude: -79.3716
- Timezone: America/Toronto
More informations about "ADMA Biologics"
About ADMA Biologics, Inc. (ADMA)
Rapidly growing and diversified commercial product portfolio and contract development and manufacturing organization (CDMO) platform; ... You are now leaving admabiologics.com The …See details»
What We Do - ADMA Biologics, Inc. (ADMA)
ADMA BioCenters is an organization specializing in the collection of human plasma used to make special medications for the treatment and prevention of diseases. ... You are now leaving …See details»
ADMA Biologics, Inc. | LinkedIn
ADMA Biologics, Inc. | 8,060 followers on LinkedIn. Hiring at our Boca Raton, FL campus! | ADMA Biologics is an end-to-end commercial biopharmaceutical company dedicated to manufacturing ...See details»
Investor Relations :: ADMA Biologics, Inc.
3Q 2024 Total Revenue of $119.8 Million, a 78% Increase Y-o-Y 3Q 2024 GAAP Net Income of $35.9 Million, a 1,300% Increase Y-o-Y 3Q 2024 Adjusted EBITDA ( 1) of $45.4 Million, a 256% Increase Y-o-Y KPMG LLP Engaged as New …See details»
ADMA Biologics, Inc. (ADMA) Company Profile & Facts - Yahoo …
See the company profile for ADMA Biologics, Inc. (ADMA) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
ADMA Biologics, Inc. (ADMA) Company Profile & Overview - Stock …
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and …See details»
ADMA Biologics Successfully Implements Innovative AI Program, …
Feb 21, 2024 Mr. Grossman continued, “The robust ADMAlytics AI program is designed to optimize and streamline our intricate production processes, delivering significant efficiencies …See details»
Senior Leadership Team - ADMA Biologics, Inc. (ADMA)
Prior to joining ADMA, Mr. Stremming was the President of Interstate Blood Bank, Inc., President of BPC, and Vice President of the Southeast Plasma Business Unit within the Grifols Organization. Mr. Stremming started his career as a …See details»
ADMA Biologics, Inc. (ADMA) - Yahoo Finance Canada
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and …See details»
ADMA Biologics Announces First Quarter 2024 Financial Results …
May 9, 2024 All told, we anticipate ADMAlytics’ ongoing rollout across the organization will provide for operational and financial benefits, including the following: increased production …See details»
Working At ADMA Biologics: Company Overview and Culture
Www.admabiologics.com. Organization Type. Public. CEO. Adam S. Grossman. Social Media. ADMA is a specialty immune globulin company that develops, manufactures and intends to …See details»
Release Details - ADMA Biologics, Inc.
Jan 17, 2023 For more information, please visit www.admabiologics.com. Forward-Looking Statements Any statements contained in this press release that do not describe historical facts …See details»
Our Products - ADMA Biologics, Inc. (ADMA)
Commercial products: Our immune globulin product portfolio. With three FDA-approved products, the mission of ADMA Biologics is to continue to successfully commercialize specialty biologics, …See details»
ADMA Biologics Receives FDA Approval for ADMA BioCenters
Aug 16, 2021 ADMA Biologics Receives FDA Approval for ADMA BioCenters Plasma Collection Facility in Maryville, TNSee details»
ADMA Biologics Announces Preliminary Fourth Quarter and Full …
Jan 17, 2023 Fourth Quarter 2022 Preliminary Unaudited Total Revenues of Approximately $49-$50 Million, an 89% Year-Over-Year Increase Full Year 2022 Preliminary Unaudited Total …See details»
ADMA Biologics Reports Fourth Quarter and Full Year 2019 …
Mar 12, 2020 According to the World Health Organization, there are approximately 350 different genetic mutations encompassing PI. ... 201-478-5552 |www.admabiologics.com. INVESTOR …See details»
Scientific Advisory Board - ADMA Biologics, Inc. (ADMA)
Dr. Casanova was elected to the European Molecular Biology Organization in 2005 and to the National Academy of Medicine and the National Academy of Sciences of the United States in …See details»
Medical Affairs - ADMA Biologics, Inc. (ADMA)
The requestor(s) should submit specific information and details as it relates to the request (organization, contact person, title of project, description of project/ timeline, budget). ... You …See details»
ADMA Biologics Announces First Quarter 2024 Financial Results …
1Q 2024 Total Revenue of $81.9 Million, a 44% Increase Y-o-Y 1Q 2024 GAAP Net Income of $17.8 Million, a $24.6 Million Increase Y-o-Y 1Q 2024 Adjusted EBITDA(1) of $26.4 Million, a …See details»